San Francisco, California
Alzheimer's disease clinical trials in San Francisco, CA
11 Alzheimer's disease studies are recruiting participants at sites in San Francisco as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
San Francisco at a glance
- 11 studies are recruiting at a site in San Francisco.
- By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (2), Phase 2 (2), Phase 3 (2), No phase (2), Observational (1). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (7), industry (4).
- Most recent update to one of these records: November 9, 2026.
Studies recruiting in San Francisco
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
CMN LIFU for Enhanced Amyloid Reduction (CLEART Study)
- No phase
- Ages 65 and older
- All sexes
- Sponsor
- University of California, San Francisco
- Study site
- University of California San Francisco
- Registry record
- NCT07866768 · updated
Alzheimer's Tau Platform: Master Protocol
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Paul S. Aisen
- Study site
- University of California, San Francisco
- Registry record
- NCT06957418 · updated
[18F]PI-2620 Phase 3 Histopathological Study
- Phase 3
- Ages 50 and older
- All sexes
- Sponsor
- Lantheus Biosciences Ltd.
- Study site
- Sutter Health
- Registry record
- NCT05641688 · updated
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- UCSF Memory and Aging Center ( Site 1031)
- Registry record
- NCT07033494 · updated
A Study of Psychedelics in Healthy Older Adults With Low Well-being
- Phase 1
- Ages 50 to 85
- All sexes
- Sponsor
- Jennifer Mitchell
- Study site
- University of California San Francisco, Sandler Neuroscience Building
- Registry record
- NCT07386730 · updated
Remotely-supervised Neuromodulation in PPA
- No phase
- Ages 40 and older
- All sexes
- Sponsor
- Maya Henry
- Study site
- UCSF Memory and Aging Cener
- Registry record
- NCT07260253 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study site
- University of California, San Francisco (UCSF)
- Registry record
- NCT06563895 · updated
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
- Early Phase 1
- Ages 40 to 85
- All sexes
- Sponsor
- University of Pennsylvania
- Study site
- University of California
- Registry record
- NCT06932809 · updated
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
- Observational
- Ages 65 and older
- All sexes
- Sponsor
- University of Southern California
- Study site
- University of California, San Francisco
- Registry record
- NCT02434393 · updated
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Phase 1/2
- Ages 18 to 80
- All sexes
- Sponsor
- Ashvattha Therapeutics, Inc.
- Registry record
- NCT05395624 · updated
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
- Phase 1/2
- Ages 40 to 75
- All sexes
- Sponsor
- David Wilson
- Study site
- China Basin, UCSF
- Registry record
- NCT05374278 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in San Francisco, CA on ClinicalTrials.gov.
Ask about studies near San Francisco
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in California
All California locations
62 studies recruiting across 36 cities.
Los Angeles
16 studies recruiting.
Irvine
10 studies recruiting.
Long Beach
9 studies recruiting.
Anaheim
8 studies recruiting.
Orange
7 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections